Records 1 - 10
| B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis.
Journal of inflammation research 2022 15 5541-5555.
Lin Anqi, Fang Jianbo, Cheng Quan, Liu Zaoqu, Luo Peng, Zhang Ji
| EPHA5 mutations predict survival after immunotherapy in lung adenocarcinoma.
Aging 2020 Dec 12 .
Chen Zhiming, Chen Ji, Ren Dandan, Zhang Jiao, Yang Ying, Zhang Henghui, Mao Beibei, Ma Hait
| The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses.
Aging 2020 Dec 12 .
Zhou Pei, Wu Xueying, Chen Huan, Hu Ying, Zhang Henghui, Wu Lijia, Yang Ying, Mao Beibei, Wang Huaqi
| The mutational pattern of homologous recombination (HR)-associated genes and its relevance to the immunotherapeutic response in gastric cancer.
Cancer biology & medicine 2020 Nov 17 (4): 1002-1013.
Fan Yue, Ying Haifeng, Wu Xueying, Chen Huan, Hu Ying, Zhang Henghui, Wu Lijia, Yang Ying, Mao Beibei, Zheng L
| Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma.
Journal of cancer research and clinical oncology 2020 Aug .
Wang Feng, Zhao Ning, Gao Ge, Deng Hong-Bin, Wang Zhi-Hui, Deng Li-Li, Yang Yu, Lu Changli
| TP53 Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Mar .
Sinn Marianne, Sinn Bruno V, Treue Denise, Keilholz Ulrich, Damm Frederik, Schmuck Rosa Bianca, Lohneis Philipp, Klauschen Frederick, Striefler Jana K, Bahra Marcus, Bläker Hendrik, Bischoff Sven, Pelzer Uwe, Oettle Helmut, Riess Hanno, Budczies Jan, Denkert Carst
| Traditional Serrated Pathway-associated Colorectal Carcinoma: Morphologic Reappraisal of Serrated Morphology, Tumor Budding, and Identification of Frequent PTEN Alterations.
The American journal of surgical pathology 2019 May .
Tsai Jia-Huei, Jeng Yung-Ming, Yuan Chang-Tsu, Lin Yu-Lin, Cheng Mei-Ling, Liau Jau-
| Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1.
Molecular cancer 2018 Apr 17 (1): 81.
Liu Liang, Ruiz Jimmy, O'Neill Stacey S, Grant Stefan C, Petty W Jeffrey, Yang Meng, Chen Kexin, Topaloglu Umit, Pasche Boris, Zhang W
| Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in Chinese patients.
Lung cancer (Amsterdam, Netherlands) 2014 Nov 86 (2): 164-9.
Chao Liu, Yi-Sheng Huang, Yu Chen, Li-Xu Yan, Xin-Lan Luo, Dong-Lan Luo, Jie Chen, Yi-Lon Wu, Hui Liu Y
| The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2014 Sep 9 (9): 1363-9.
Izar Benjamin, Zhou Haiyu, Heist Rebecca S, Azzoli Christopher G, Muzikansky Alona, Scribner Emily E F, Bernardo Lindsay A, Dias-Santagata Dora, Iafrate Anthony J, Lanuti Micha